The Age
·general
·4 hours ago
‘Unviable’: 450,000 Australians to miss out on subsidised weight loss drug
Eli Lilly declined to subsidise its weight loss drug Mounjaro, leaving an estimated 450,000 Australians without access. The Pharmaceutical Benefits Advisory Committee noted the need for more treatment options, but Eli Lilly's general manager Manny Simons called the government's price offer unrealistic. This decision may hinder future efforts to secure the drug's listing for obesity-related conditions.
Summary by Glance · The Age
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI